El‐Hefnawy 2010.
Methods | RCT comparing Gynecare TVT R and Aris TOTR outside‐in | |
Participants | 40 women Inclusion criteria: women with urodynamically proven SUI Exclusion criteria: women who reported urgency incontinence as predominant complaint; had pelvic or vaginal surgery within the preceding 6 months; had associated urethral and/or bladder pathology or active UTI; neuropathic bladder; POP > stage 2 (Baden Walker classification) Mean age (years; SD): Group A:47 (5); Group B: 45 (7) Concomitant POP stage 1‐2: Group A: 10; Group B: 13 Mean BMI kg/m² (SD): Group A: 34 (5); Group B: 32(5) |
|
Interventions | Preliminary results: Group A: TVT: (n = 19) Group B: TOT: (n = 21) At 24 months: Group A: TVT: (n = 45) Group B: TOT: (n = 42) |
|
Outcomes | Follow‐up at 3, 6, 12 and 24 months
|
|
Notes | Intraoperative cystoscopy carried out only in the TVT group to exclude bladder or urethral injury Concomittant surgery was performed in 9 participants; 5 participants underwent abdominal hysterectomy, 4 participants underwent anterior colporrhaphy Lost to follow‐up at 12 months: Group A: 0/19; Group B: 0/21 Lost to follow‐up at 24 months: Group A: 9/45; Group B: 7/42 |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | "Patient’s randomisation is accomplished through closed envelopes. A randomly selected envelope is dispatched to a running nurse with the patient’s name and ID hand typed on the envelope" |
Allocation concealment (selection bias) | Low risk | Quote: “randomisation is accomplished through closed envelopes. A randomly selected envelope is dispatched to a running nurse with the patient’s name and ID hand typed on the envelope” |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | No information |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Quote: “Follow up was carried out by a nurse blinded to the procedure” |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All outcomes included |